FDA recall, , Low risk
HCSC-Blood Center Apheresis Platelets, Leukocytes Reduced
Apheresis Platelets, Leukocytes Reduced were exposed to unacceptable storage temperatures.
Recall ended Sep 21, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
HCSC-Blood Center began a recall of Apheresis Platelets, Leukocytes Reduced on July 9, 2025, because the products were exposed to unacceptable storage temperatures. The recall was added to the FDA's Enforcement Report on September 21, 2026, and the products were distributed in Tennessee.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Platelets, Leukocytes Reduced
- Affected units
- W050925203778 (double collection); W050925104240 (double collection); W050925104235 (double collection); W050925203775 (double collection); W050925304026 (double collection); W050925304023 (double collection)
Recall details
- Company began the recall
- Sold in
- Company
- HCSC-Blood Center
- Hazard
- Processing problem
- Risk
Low risk
Taking it is unlikely to cause health problems.
FDA Class III recall · How risk is rated
- Event ID
- 99645
- Recall number
- B-0239-2026
All recalls from HCSC-Blood Center
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
